Fenofibrate and Tasigna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Tasigna (nilotinib hydrochloride monohydrate). Common drug interactions include cough among females and intermittent claudication among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Tasigna. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

On Aug, 01, 2026

53 people who take Fenofibrate and Tasigna together, and have interactions are studied.

Fenofibrate and Tasigna drug interactions.

What are the common drug interactions of Fenofibrate and Tasigna, by gender? *:

female:

Cough
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dizziness
Feeding disorder (when children refuse to eat certain food groups)
Full blood count increased
Globulins increased
Haemoglobin decreased
Headache (pain in head)
Herpes zoster
Hyperglycaemia (high blood sugar)

male:

Intermittent claudication
Lipase increased
Weight decreased
Abdominal pain
Amylase increased
Cough
Hyperglycaemia (high blood sugar)
Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
Poor peripheral circulation
Rhinorrhoea (watery mucus discharge from the nose)

What are the common drug interactions of Fenofibrate and Tasigna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaemia (lack of blood)
Immunosuppression
Malaise (a feeling of general discomfort or uneasiness)

30-39:

n/a

40-49:

Abdominal distension
Cerebral artery stenosis (hardening of brain blood vessels)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Diarrhoea
Lipase increased
Nausea (feeling of having an urge to vomit)
Pancreatic disorder
Pneumonia
Weight decreased

50-59:

Cough
Rhinorrhoea (watery mucus discharge from the nose)
Autoimmune hepatitis
Fatigue (feeling of tiredness)
Liver injury
Muscle spasms (muscle contraction)
Arthralgia (joint pain)
Blood creatine phosphokinase increased
Blood glucose increased
Blood pressure increased

60+:

Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
Concomitant disease progression (progress in accompanying disease)
Blood glucose increased
Dyspepsia (indigestion)
Weight decreased
Chest pain
Abdominal discomfort
Abdominal distension
Alopecia (absence of hair from areas of the body)
Bone pain

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 35 people, 66.04%
Neoplasm Malignant (cancer tumour): 4 people, 7.55%
Leukaemia (blood or bone marrow cancer): 4 people, 7.55%
High Blood Pressure: 3 people, 5.66%
Dyslipidaemia (abnormal amount of lipids): 3 people, 5.66%
Diabetes: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Tasigna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously